Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT04566887 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04566887
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2028-09-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.